Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Correct calibration procedure for the Q-switched ruby laser and checking the treatment irradiation pattern.

Ohshiro T, Ohshiro T, Sasaki K, Takenouchi K, Kozuma M, Ohshiro N, Kageyama Y.

Laser Ther. 2013;22(3):171-80. doi: 10.3136/islsm.22.171.

2.

Partial breast reconstruction for an inferomedial breast carcinoma using an omental flap.

Zaha H, Sunagawa H, Kawakami K, Touyama T, Yonaha T, Ohshiro N.

World J Surg. 2010 Aug;34(8):1782-7. doi: 10.1007/s00268-010-0535-z.

PMID:
20352214
3.

Isolation and functional characterization of a novel organic solute carrier protein, hOSCP1.

Kobayashi Y, Shibusawa A, Saito H, Ohshiro N, Ohbayashi M, Kohyama N, Yamamoto T.

J Biol Chem. 2005 Sep 16;280(37):32332-9. Epub 2005 Jul 8.

4.

Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]).

Kobayashi Y, Ohshiro N, Sakai R, Ohbayashi M, Kohyama N, Yamamoto T.

J Pharm Pharmacol. 2005 May;57(5):573-8.

PMID:
15901346
5.

Possible involvement of organic anion transporter 2 on the interaction of theophylline with erythromycin in the human liver.

Kobayashi Y, Sakai R, Ohshiro N, Ohbayashi M, Kohyama N, Yamamoto T.

Drug Metab Dispos. 2005 May;33(5):619-22. Epub 2005 Feb 11.

PMID:
15708966
6.

Convergent synthesis of platinum-acetylide dendrimers.

Onitsuka K, Fujimoto M, Kitajima H, Ohshiro N, Takei F, Takahashi S.

Chemistry. 2004 Dec 3;10(24):6433-46.

PMID:
15540268
7.

Renal transport of organic compounds mediated by mouse organic anion transporter 3 (mOat3): further substrate specificity of mOat3.

Kobayashi Y, Ohshiro N, Tsuchiya A, Kohyama N, Ohbayashi M, Yamamoto T.

Drug Metab Dispos. 2004 May;32(5):479-83.

PMID:
15100168
8.

Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice.

Kobayashi Y, Ohshiro N, Shibusawa A, Sasaki T, Tokuyama S, Sekine T, Endou H, Yamamoto T.

Mol Pharmacol. 2002 Jul;62(1):7-14.

PMID:
12065749
9.

Induction and inhibition of cytochrome P450 and drug-metabolizing enzymes by climbazole.

Kobayashi Y, Suzuki M, Ohshiro N, Sunagawa T, Sasaki T, Oguro T, Tokuyama S, Yamamoto T, Yoshida T.

Biol Pharm Bull. 2002 Jan;25(1):53-7.

10.

Differential gene expression of organic anion transporters in male and female rats.

Kobayashi Y, Hirokawa N, Ohshiro N, Sekine T, Sasaki T, Tokuyama S, Endou H, Yamamoto T.

Biochem Biophys Res Commun. 2002 Jan 11;290(1):482-7.

PMID:
11779196
11.

Climbazole is a new potent inducer of rat hepatic cytochrome P450.

Kobayashi Y, Suzuki M, Ohshiro N, Sunagawa T, Sasaki T, Tokuyama S, Yamamoto T, Yoshida T.

J Toxicol Sci. 2001 Aug;26(3):141-50.

12.

Effect of 4-(4-chlorobenzyl)pyridine on rat hepatic microsomal cytochrome P450 and drug-metabolizing enzymes in vivo and in vitro.

Kobayashi Y, Ohshiro N, Sasaki T, Tokuyama S, Tobe T, Yoshida T, Yamamoto T.

Biol Pharm Bull. 2001 May;24(5):505-9.

13.

Sex-related effect of hemin on cytochrome P450 and drug-metabolizing enzymes in rat liver.

Kobayashi Y, Ohshiro N, Suzuki M, Sasaki T, Tokuyama S, Yoshida T, Yamamoto T.

J Toxicol Sci. 2000 Aug;25(3):213-22.

PMID:
10987129
14.

Concurrent induction of rat hepatic microsomal cytochrome P450 and haem oxygenase by 2,2'-dipyridyl ketone: comparison with the effect of 2,2'-dipyridyl amine.

Kobayashi Y, Ohshiro N, Okui E, Sasaki T, Tokuyama S, Yoshida T, Yamamoto T.

Xenobiotica. 2000 Jul;30(7):683-92.

PMID:
10963059
15.

Convergent Route to Organometallic Dendrimers Composed of Platinum-Acetylide Units.

Onitsuka K, Fujimoto M, Ohshiro N, Takahashi S.

Angew Chem Int Ed Engl. 1999 Mar 1;38(5):689-692. doi: 10.1002/(SICI)1521-3773(19990301)38:5<689::AID-ANIE689>3.0.CO;2-D.

PMID:
29711540

Supplemental Content

Loading ...
Support Center